Key Metrics
CiteScore 

2.24
H-Index 

44
SNIP 

0.72
Recommended pre-submission checks
Powered by 

Topics Covered on MedChemComm
MedChemComm Journal Specifications
Indexed in the following public directories
CrossRef
SJR
Scopus
| Overview | |
| Publisher | Royal Society of Chemistry |
Planning to publish in MedChemComm ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in MedChemComm
Probing pyrazolo-pyrimidines as SIRT2 inhibitors via molecular modelling and biological assays
- 29 Jul 2026
- RSC Medicinal Chemistry
Synthesis and anti-inflammatory activity evaluation of pterostilbene-based phthalide derivatives.
- 28 Jul 2026
- RSC medicinal chemistry
Integrated platform for accelerating therapeutic macrocyclic peptide purification in high-throughput medicinal chemistry.
- 27 Jul 2026
- RSC medicinal chemistry
Peptide-drug conjugation: a strategy to address blood-brain barrier limitations in central nervous system diseases.
- 27 Jul 2026
- RSC medicinal chemistry
Targeting PRMTs with small-molecule inhibitors: a comprehensive review.
- 27 Jul 2026
- RSC medicinal chemistry
Discovery of spirocyclic amide scaffolds as novel neddylation E1 inhibitors to suppress the growth and survival of lung cancer cells.
- 17 Jul 2026
- RSC medicinal chemistry
Probing pyrazolo-pyrimidines as SIRT2 inhibitors via molecular modelling and biological assays
- 29 Jul 2026
- RSC Medicinal Chemistry
Synthesis and anti-inflammatory activity evaluation of pterostilbene-based phthalide derivatives.
- 28 Jul 2026
- RSC medicinal chemistry
Integrated platform for accelerating therapeutic macrocyclic peptide purification in high-throughput medicinal chemistry.
- 27 Jul 2026
- RSC medicinal chemistry
Peptide-drug conjugation: a strategy to address blood-brain barrier limitations in central nervous system diseases.
- 27 Jul 2026
- RSC medicinal chemistry
Targeting PRMTs with small-molecule inhibitors: a comprehensive review.
- 27 Jul 2026
- RSC medicinal chemistry
Discovery of spirocyclic amide scaffolds as novel neddylation E1 inhibitors to suppress the growth and survival of lung cancer cells.
- 17 Jul 2026
- RSC medicinal chemistry